4.0 Review

Paracetamol as an adjuvant to opioids for cancer pain management

期刊

REVISTA MEDICA DE CHILE
卷 149, 期 6, 页码 899-905

出版社

SOC MEDICA SANTIAGO

关键词

Acetaminophen; Analgesics; Opioid; Cancer Pain

向作者/读者索取更多资源

Cancer-related pain significantly affects the quality of life for patients, and the combination of paracetamol and strong opioids can reduce opioid side effects. However, there is uncertainty regarding the role of paracetamol as an adjuvant in cancer pain patients.
Cancer related pain is one of the most frequent and relevant symptoms in patients with malignant tumors, causing a huge impact in their quality of life. According to the Chilean Public Health System Technical Report of the Cancer Pain Control and Palliative Care Program 2013-2014, 90% of cancer patients admitted to the Program experienced pain, being moderate or intense in 34%. International and local standards recommend the use of strong opioids (morphine, methadone, or fentanyl) associated with adjuvants such as paracetamol as an initial strategy for pain management. This recommendation assumes that the use of combined analgesics could allow the use of lower opioid doses to obtain similar analgesic effect, decreasing the occurrence of opioid side effects. However, this technical report also describes that there is uncertainty about the impact of paracetamol as an adjuvant in patients with cancer pain who are already receiving strong opioids. This review aims to describe the current state of the art regarding the role of paracetamol as a coadjuvant in cancer pain patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据